Pellagra and pellagra-like erythema in a hospital setting in Lomé, Togo : retrospective study from 1997 to 2017.

Pellagre et érythèmes pellagroïdes en milieu hospitalier à Lomé, Togo : étude rétrospective de 1997 à 2017.

Journal

Medecine et sante tropicales
ISSN: 2261-2211
Titre abrégé: Med Sante Trop
Pays: France
ID NLM: 101581406

Informations de publication

Date de publication:
01 Feb 2019
Historique:
entrez: 30 4 2019
pubmed: 30 4 2019
medline: 18 12 2019
Statut: ppublish

Résumé

The aim of this study was to describe the epidemiological, clinical, and therapeutic profile as well as the outcome and to document the causes of pellagra and pellagra-like erythema in a hospital setting in Lomé, Togo. This retrospective study examined the records of patients seen for outpatient consultation and/or hospitalization in the three public dermatology departments of Lomé from January 1997 to September 2017. During the study period, 178 (0.4%) of 47,219 patients seen in these dermatology departments consulted for pellagra or pellagra-like erythema; 159 (89.3%) had pellagra-like erythema. The patients' mean age was 45.8±16 years, and the sex ratio (M/F) 1.8. All patients had at least one site of cutaneous involvement, nearly always erythematous or pigmented lesions in the photo-exposed areas (99.4% of cases). Gastrointestinal and neurological signs were dominated respectively by diarrhea (12.4 % of cases), peripheral neuropathies (8.4% of cases) and insomnia (8.4% of cases). The main causes identified were alcoholism (42.1% of cases) and nutritional deficiency (6.7% of cases). Five of 178 patients were infected with HIV. All patients were treated with nicotinamide and multivitamin supplementation. No deaths were recorded during follow-up. Our results document the extreme rarity of pellagra-like erythema/pellagra. Its two main causes remain alcoholism and nutritional deficiency. Moreover, its prognosis is good when treated quickly and adequately.

Identifiants

pubmed: 31031251
pii: mst.2018.0856
doi: 10.1684/mst.2018.0856
doi:

Substances chimiques

Vitamin B Complex 12001-76-2
Niacinamide 25X51I8RD4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

68-70

Auteurs

A S Akakpo (AS)

Service dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, 14BP 200 Lomé, Togo.

B Saka (B)

Service dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, 14BP 200 Lomé, Togo.

J N Teclessou (JN)

Service dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, 14BP 200 Lomé, Togo.

A Mouhari-Toure (A)

Service de dermatologie du CHU Kara, Université de KARA, Togo.

Y Moise Elegbede (Y)

Service de dermatologie du CHU Kara, Université de KARA, Togo.

K Kombate (K)

Service dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, 14BP 200 Lomé, Togo.

K Tchangai-Walla (K)

Service dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, 14BP 200 Lomé, Togo.

P Pitche (P)

Service dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, 14BP 200 Lomé, Togo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH